Melatonin uptake in prostate cancer cells

Intracellular transport versus simple passive diffusion

David Hevia, Rosa M. Sainz, Domingo Blanco, Isabel Quirós, Dun Xian Tan, Carmen Rodríguez, Juan C. Mayo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Melatonin, an indole mainly synthesized in the pineal gland during the dark phase, plays a role as an endogenous antioxidant and an anticancer agent in many tumors. Melatonin, at pharmacological concentrations, inhibits cell growth and induces neuroendocrine differentiation in prostate cancer cells. Classically it has been considered that melatonin enters freely into most of cells by passive diffusion through the cell membrane; however, there are few studies examining how melatonin is taken up by cancer cells. The aim of the present paper was to study the uptake of melatonin into human androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cells. Increased concentrations of melatonin induced a rapid and transitory rise in intracellular melatonin content in both cell types, with a peak of maximal content at 6 hr after melatonin addition, following a rhythmic uptake; melatonin was found in both cytoplasm and nuclear fractions. Inhibition of protein or RNA synthesis partially blocked melatonin uptake in both cell lines. Interestingly, melatonin pulse incubation led to a higher uptake after four cycles of pulse incubation. Neither extracellular Ca2+/K+ alterations nor the presence of bovine serum albumin or charcoal-stripped serum modified the profile of melatonin uptake. On the contrary, chemical binding of melatonin to BSA totally prevented melatonin from entering into cells. The present data support the hypothesis that a facilitated diffusion or an active process rather than simple passive diffusion through the cell membrane is the major mechanism in melatonin uptake by prostate cancer cells and it accounts for its intracellular concentration (350 nm-3.3 μm), which is related to its anti-tumor actions.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalJournal of Pineal Research
Volume45
Issue number3
DOIs
StatePublished - Oct 2008

Fingerprint

Melatonin
Prostatic Neoplasms
Androgens
Cell Membrane
Facilitated Diffusion
Neoplasms
Pineal Gland
Charcoal
Bovine Serum Albumin
Antineoplastic Agents
Cytoplasm

Keywords

  • Antiproliferative
  • Intracellular concentration
  • Melatonin
  • Prostate cancer
  • Uptake

ASJC Scopus subject areas

  • Endocrinology

Cite this

Hevia, D., Sainz, R. M., Blanco, D., Quirós, I., Tan, D. X., Rodríguez, C., & Mayo, J. C. (2008). Melatonin uptake in prostate cancer cells: Intracellular transport versus simple passive diffusion. Journal of Pineal Research, 45(3), 247-257. https://doi.org/10.1111/j.1600-079X.2008.00581.x

Melatonin uptake in prostate cancer cells : Intracellular transport versus simple passive diffusion. / Hevia, David; Sainz, Rosa M.; Blanco, Domingo; Quirós, Isabel; Tan, Dun Xian; Rodríguez, Carmen; Mayo, Juan C.

In: Journal of Pineal Research, Vol. 45, No. 3, 10.2008, p. 247-257.

Research output: Contribution to journalArticle

Hevia, D, Sainz, RM, Blanco, D, Quirós, I, Tan, DX, Rodríguez, C & Mayo, JC 2008, 'Melatonin uptake in prostate cancer cells: Intracellular transport versus simple passive diffusion', Journal of Pineal Research, vol. 45, no. 3, pp. 247-257. https://doi.org/10.1111/j.1600-079X.2008.00581.x
Hevia, David ; Sainz, Rosa M. ; Blanco, Domingo ; Quirós, Isabel ; Tan, Dun Xian ; Rodríguez, Carmen ; Mayo, Juan C. / Melatonin uptake in prostate cancer cells : Intracellular transport versus simple passive diffusion. In: Journal of Pineal Research. 2008 ; Vol. 45, No. 3. pp. 247-257.
@article{30577a176500486d90ab43bd18f86c59,
title = "Melatonin uptake in prostate cancer cells: Intracellular transport versus simple passive diffusion",
abstract = "Melatonin, an indole mainly synthesized in the pineal gland during the dark phase, plays a role as an endogenous antioxidant and an anticancer agent in many tumors. Melatonin, at pharmacological concentrations, inhibits cell growth and induces neuroendocrine differentiation in prostate cancer cells. Classically it has been considered that melatonin enters freely into most of cells by passive diffusion through the cell membrane; however, there are few studies examining how melatonin is taken up by cancer cells. The aim of the present paper was to study the uptake of melatonin into human androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cells. Increased concentrations of melatonin induced a rapid and transitory rise in intracellular melatonin content in both cell types, with a peak of maximal content at 6 hr after melatonin addition, following a rhythmic uptake; melatonin was found in both cytoplasm and nuclear fractions. Inhibition of protein or RNA synthesis partially blocked melatonin uptake in both cell lines. Interestingly, melatonin pulse incubation led to a higher uptake after four cycles of pulse incubation. Neither extracellular Ca2+/K+ alterations nor the presence of bovine serum albumin or charcoal-stripped serum modified the profile of melatonin uptake. On the contrary, chemical binding of melatonin to BSA totally prevented melatonin from entering into cells. The present data support the hypothesis that a facilitated diffusion or an active process rather than simple passive diffusion through the cell membrane is the major mechanism in melatonin uptake by prostate cancer cells and it accounts for its intracellular concentration (350 nm-3.3 μm), which is related to its anti-tumor actions.",
keywords = "Antiproliferative, Intracellular concentration, Melatonin, Prostate cancer, Uptake",
author = "David Hevia and Sainz, {Rosa M.} and Domingo Blanco and Isabel Quir{\'o}s and Tan, {Dun Xian} and Carmen Rodr{\'i}guez and Mayo, {Juan C.}",
year = "2008",
month = "10",
doi = "10.1111/j.1600-079X.2008.00581.x",
language = "English (US)",
volume = "45",
pages = "247--257",
journal = "Journal of Pineal Research",
issn = "0742-3098",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Melatonin uptake in prostate cancer cells

T2 - Intracellular transport versus simple passive diffusion

AU - Hevia, David

AU - Sainz, Rosa M.

AU - Blanco, Domingo

AU - Quirós, Isabel

AU - Tan, Dun Xian

AU - Rodríguez, Carmen

AU - Mayo, Juan C.

PY - 2008/10

Y1 - 2008/10

N2 - Melatonin, an indole mainly synthesized in the pineal gland during the dark phase, plays a role as an endogenous antioxidant and an anticancer agent in many tumors. Melatonin, at pharmacological concentrations, inhibits cell growth and induces neuroendocrine differentiation in prostate cancer cells. Classically it has been considered that melatonin enters freely into most of cells by passive diffusion through the cell membrane; however, there are few studies examining how melatonin is taken up by cancer cells. The aim of the present paper was to study the uptake of melatonin into human androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cells. Increased concentrations of melatonin induced a rapid and transitory rise in intracellular melatonin content in both cell types, with a peak of maximal content at 6 hr after melatonin addition, following a rhythmic uptake; melatonin was found in both cytoplasm and nuclear fractions. Inhibition of protein or RNA synthesis partially blocked melatonin uptake in both cell lines. Interestingly, melatonin pulse incubation led to a higher uptake after four cycles of pulse incubation. Neither extracellular Ca2+/K+ alterations nor the presence of bovine serum albumin or charcoal-stripped serum modified the profile of melatonin uptake. On the contrary, chemical binding of melatonin to BSA totally prevented melatonin from entering into cells. The present data support the hypothesis that a facilitated diffusion or an active process rather than simple passive diffusion through the cell membrane is the major mechanism in melatonin uptake by prostate cancer cells and it accounts for its intracellular concentration (350 nm-3.3 μm), which is related to its anti-tumor actions.

AB - Melatonin, an indole mainly synthesized in the pineal gland during the dark phase, plays a role as an endogenous antioxidant and an anticancer agent in many tumors. Melatonin, at pharmacological concentrations, inhibits cell growth and induces neuroendocrine differentiation in prostate cancer cells. Classically it has been considered that melatonin enters freely into most of cells by passive diffusion through the cell membrane; however, there are few studies examining how melatonin is taken up by cancer cells. The aim of the present paper was to study the uptake of melatonin into human androgen-dependent LNCaP and androgen-independent PC-3 prostate cancer cells. Increased concentrations of melatonin induced a rapid and transitory rise in intracellular melatonin content in both cell types, with a peak of maximal content at 6 hr after melatonin addition, following a rhythmic uptake; melatonin was found in both cytoplasm and nuclear fractions. Inhibition of protein or RNA synthesis partially blocked melatonin uptake in both cell lines. Interestingly, melatonin pulse incubation led to a higher uptake after four cycles of pulse incubation. Neither extracellular Ca2+/K+ alterations nor the presence of bovine serum albumin or charcoal-stripped serum modified the profile of melatonin uptake. On the contrary, chemical binding of melatonin to BSA totally prevented melatonin from entering into cells. The present data support the hypothesis that a facilitated diffusion or an active process rather than simple passive diffusion through the cell membrane is the major mechanism in melatonin uptake by prostate cancer cells and it accounts for its intracellular concentration (350 nm-3.3 μm), which is related to its anti-tumor actions.

KW - Antiproliferative

KW - Intracellular concentration

KW - Melatonin

KW - Prostate cancer

KW - Uptake

UR - http://www.scopus.com/inward/record.url?scp=51649114311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51649114311&partnerID=8YFLogxK

U2 - 10.1111/j.1600-079X.2008.00581.x

DO - 10.1111/j.1600-079X.2008.00581.x

M3 - Article

VL - 45

SP - 247

EP - 257

JO - Journal of Pineal Research

JF - Journal of Pineal Research

SN - 0742-3098

IS - 3

ER -